Scholarlink

<p>This study aimed to explore the synergistic effect of lipid accumulation product (LAP) and visceral adiposity index (VAI) on diabetes risk, and to evaluate the potential associations of these novel metabolic markers with diabetes. The current cross-sectional survey utilised data from the 2015–2018 National Health and Nutrition Examination Survey (NHANES). The relationship between LAP and VAI levels and diabetes was examined using multiple logistic regression analysis. Moreover, threshold effects analysis and smoothed curve fitting were used as analytical techniques. The diabetes group exhibited significantly higher LAP (90.1 ± 84.1) and VAI (2.8 ± 2.8) levels compared to the non-diabetes group (<i>p</i> &lt; 0.0001).After adjusting for confounding factors, LAP (OR = 1.01, 95% CI: 1.00–1.01, <i>p</i> &lt; 0.0001) and VAI (OR = 1.22, 95% CI: 1.16–1.28, <i>p</i> &lt; 0.0001) were independently associated with diabetes risk. The interaction term (LAP x VAI) showed a significant synergistic effect (OR = 1.01, 95% CI: 1.00–1.07, <i>p</i> = 0.0042).Diabetes risk significantly increased when LAP was below 97.70 (OR = 1.03, 95% CI: 1.02–1.03, <i>p</i> &lt; 0.0001) and when VAI was below 3.76 (OR = 1.88, 95% CI: 1.69–2.08, <i>p</i> &lt; 0.0001). According to this study, LAP and VAI are independent predictors of diabetes risk and exhibit a significant synergistic effect. Combining these indices may improve the accuracy of diabetes screening.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Perspective from NHANES data: synergistic effects of visceral adiposity index and lipid accumulation products on diabetes risk

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年1月2日

查看全文
  • JianHua He,
  • Lei Chen

摘要

This study aimed to explore the synergistic effect of lipid accumulation product (LAP) and visceral adiposity index (VAI) on diabetes risk, and to evaluate the potential associations of these novel metabolic markers with diabetes. The current cross-sectional survey utilised data from the 2015–2018 National Health and Nutrition Examination Survey (NHANES). The relationship between LAP and VAI levels and diabetes was examined using multiple logistic regression analysis. Moreover, threshold effects analysis and smoothed curve fitting were used as analytical techniques. The diabetes group exhibited significantly higher LAP (90.1 ± 84.1) and VAI (2.8 ± 2.8) levels compared to the non-diabetes group (p < 0.0001).After adjusting for confounding factors, LAP (OR = 1.01, 95% CI: 1.00–1.01, p < 0.0001) and VAI (OR = 1.22, 95% CI: 1.16–1.28, p < 0.0001) were independently associated with diabetes risk. The interaction term (LAP x VAI) showed a significant synergistic effect (OR = 1.01, 95% CI: 1.00–1.07, p = 0.0042).Diabetes risk significantly increased when LAP was below 97.70 (OR = 1.03, 95% CI: 1.02–1.03, p < 0.0001) and when VAI was below 3.76 (OR = 1.88, 95% CI: 1.69–2.08, p < 0.0001). According to this study, LAP and VAI are independent predictors of diabetes risk and exhibit a significant synergistic effect. Combining these indices may improve the accuracy of diabetes screening.